Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey Results
Ruth Tal-Singer,1 Kristen S Willard,1 Mark A Luttmann,1 Madison Sprankle,1 Jenna Reynolds,2 Irantzu Muerza Santos,3 Hannah Jaffee,4 Anna Vichiendilokkul,5 Cristina Jacomelli,6 Špela Novak,7 Victor Gascon Moreno,7 Robert A Wise8 1Global Allergy & Airways Patient Platform, Hendersonville, TN, USA;...
Saved in:
| Main Authors: | Tal-Singer R, Willard KS, Luttmann MA, Sprankle M, Reynolds J, Muerza Santos I, Jaffee H, Vichiendilokkul A, Jacomelli C, Novak Š, Gascon Moreno V, Wise RA |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Patient Preference and Adherence |
| Subjects: | |
| Online Access: | https://www.dovepress.com/disease-impact-and-perception-of-biologics-in-adults-with-type-2-infla-peer-reviewed-fulltext-article-PPA |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tezepelumab achieves improvement of severe uncontrolled asthma and rhinosinusitis: Case series
by: Shigesato Inoue, MD, et al.
Published: (2025-05-01) -
Tezepelumab treatment in severe asthma with recurrent chronic rhinosinusitis with nasal polyps: Case series
by: Yoshiro Kai, MD, PhD
Published: (2025-05-01) -
The roles of nasal nitric oxide in diagnosis and endotypes of chronic rhinosinusitis with nasal polyps
by: Mengdi Zhu, et al.
Published: (2020-09-01) -
Association of Sinonasal Symptoms and Disease With Immune Checkpoint Inhibitor Therapy
by: Jaynelle Gao, et al.
Published: (2025-06-01) -
Chronic rhinosinusitis
by: Stephani Schmidt
Published: (2015-09-01)